PANews reported on September 8th that according to a report by Jinshi Yinjin Yicai, on the evening of September 8th, in response to the news that "Yushu Technology's expected IPO valuation is as high as 50 billion yuan," a representative from Yushu Technology responded to reporters: "As of now, there has been no discussion of IPO valuation within or outside the company, and the relevant valuation information is false."PANews reported on September 8th that according to a report by Jinshi Yinjin Yicai, on the evening of September 8th, in response to the news that "Yushu Technology's expected IPO valuation is as high as 50 billion yuan," a representative from Yushu Technology responded to reporters: "As of now, there has been no discussion of IPO valuation within or outside the company, and the relevant valuation information is false."

Yushu responds to IPO valuation of 50 billion yuan: The news is false

2025/09/08 19:55

PANews reported on September 8th that according to a report by Jinshi Yinjin Yicai, on the evening of September 8th, in response to the news that "Yushu Technology's expected IPO valuation is as high as 50 billion yuan," a representative from Yushu Technology responded to reporters: "As of now, there has been no discussion of IPO valuation within or outside the company, and the relevant valuation information is false."

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.00079
$0.00079$0.00079
-1.25%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.